← Back to Clinical Trials
Recruiting NCT06643104

NCT06643104 3D Imaging Assessment of Scoliosis: Back Height Difference vs. Trunk Rotation Angle

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06643104
Status Recruiting
Phase
Sponsor The First Affiliated Hospital of Zhejiang Chinese Medical University
Condition Adolescent Idiopathic Scoliosis
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2022-01-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
Tuina

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2022-01-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study focuses on adolescents with idiopathic scoliosis, employing 3D imaging technology with depth cameras to measure back height difference (BHD) and angle of trunk rotation (ATR) before and after conventional treatments such as massage, exercise therapy, and bracing. Statistical analyses are conducted to verify the correlation between BHD and ATR and to assess the sensitivity of BHD in evaluating short-term treatment effectiveness.

Eligibility Criteria

Inclusion Criteria: (1) Adolescents aged 10-18 years, diagnosed with adolescent idiopathic scoliosis (AIS) with a Cobb angle ≥10°; (2) No history of spinal surgery or other corrective treatments; (3) Able to undergo short-term inpatient treatment (5 days) and comply with study procedures. Exclusion Criteria: (1) Patients with congenital, neuromuscular, or other secondary scoliosis; (2) Presence of major comorbidities affecting spinal structure or muscle tone (e.g., spinal cord injury, muscular dystrophy); (3) Patients unable to complete standardized assessment procedures.

Contact & Investigator

Central Contact

Honggen Du

✉ 1165374551@qq.com

📞 13958088996

Frequently Asked Questions

Who can join the NCT06643104 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Adolescent Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06643104 currently recruiting?

Yes, NCT06643104 is actively recruiting participants. Contact the research team at 1165374551@qq.com for enrollment information.

Where is the NCT06643104 trial being conducted?

This trial is being conducted at Hangzhou, China.

Who is sponsoring the NCT06643104 clinical trial?

NCT06643104 is sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology